Address
MedImmune Ventures Inc
One MedImmune Way
Gaithersburg, MD 20878
United States
Phone
Email
Website
Recent investment activity
KANDO id: 3030
Corporate information
Registration country
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 30| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | |||
|
|
Applied Genetic Technologies Corp | A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. | N/A | |||
|
|
Arginetix Inc | Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. | Seed | |||
|
|
Catabasis Pharmaceuticals Inc | Series A | ||||
|
|
Catabasis Pharmaceuticals Inc | Series A | ||||
|
|
Cellective Therapeutics Inc | N/A | ||||
|
|
Coferon Inc | Develops orally active drugs that act like small drug molecules, can permeate cell membranes, and once inside, can assemble into larger molecules | Series B | |||
|
|
Corridor Pharmaceuticals Inc | N/A | ||||
|
|
Critical Therapeutics Inc | Discoverer, developer and commercialize novel therapies. | N/A | |||
|
|
Elusys Therapeutics Inc | Develops antibody-based therapies to treat infectious diseases. | N/A | |||
|
|
Hydra Biosciences Inc | N/A | ||||
|
|
Inotek Pharmaceuticals Corp | Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. | N/A | |||
|
|
Iomai Corp | Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. | Series C | |||
|
|
LigoCyte Pharmaceuticals Inc | N/A | ||||
|
|
LigoCyte Pharmaceuticals Inc | N/A | ||||
|
|
NeuProtect Pty Ltd | N/A | ||||
|
|
NKT Therapeutics Inc | N/A | ||||
|
|
Rib-X Pharmaceuticals Inc | N/A | ||||
|
|
Sequoia Pharmaceuticals Inc | Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. | N/A | |||
|
|
Synovex Corp | N/A | ||||
|
|
Tercica Inc | A biopharmaceutical company developing new therapeutics for endocrine system disorders. | N/A | |||
|
|
Vanda Pharmaceuticals Inc | Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. | N/A | |||
|
|
VaxInnate Corp | N/A | ||||
|
|
VaxInnate Inc | A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. | Series C | |||
|
|
VentiRx Pharmaceuticals Inc | N/A |
Current team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Edward Mathers | New Enterprise Associates Inc |